Core Cap Advisors, LLC Apellis Pharmaceuticals, Inc. Transaction History

Core Cap Advisors, LLC

  • $2.12 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$43.24 - $61.04 $12,972 - $18,312
300 New
300 $15,000
Q2 2022

Aug 11, 2022
BUY
$35.07 - $59.21 $10,521 - $17,763
300 New
300 $14,000
Q1 2022

Apr 29, 2022
SELL
$35.46 - $54.12 $10,638 - $16,236
-300 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$30.74 - $49.16 $9,222 - $14,747
300 New
300 $14,000

Others Institutions Holding APLS

# of Institutions
300
Shares Held
111M
Call Options Held
2.63M
Put Options Held
845K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.67B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email